Ascendis Pharma A/S, a Denmark-based specialty pharmaceutical company with new prodrug technology, has raised $60 million from a syndicate co-led by US-based Sofinnova Ventures. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals
